Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term refers to as-yet-unidentified molecular entities involved in the detection of changes in blood gases (oxygen, carbon dioxide, protons) and the modulation of breathing by peripheral chemoreceptors (primarily in the carotid body) and central respiratory centers (such as those in the medulla oblongata and brainstem)[1][2][3][4][5]. Current research has identified some known players—such as ATP-mediated signaling, P2X receptors, the olfactory receptor Olfr78 (for lactate sensing), and type I glomus cells in the carotid body—but acknowledges that additional molecular pathways and targets remain uncharacterized or not fully understood[2][3][4]. Therefore, the phrase "unknown molecular targets" is not suitable as a structured therapeutic or research target entry and highlights an area of ongoing investigation rather than a discrete molecule, receptor, or gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Unknown molecular targets in peripheral chemoreceptors and central respiratory centers.